Magnetic resonance surveillance reduces mortality in women at high risk of BRCA1 breast cancer
An international study, published in the JAMA Oncology journal, in which the Clinical Oncology group of the…
An international study, published in the JAMA Oncology journal, in which the Clinical Oncology group of the…
A new research paper was published in Oncotarget’s Volume 15 on February 22, 2024, entitled, “Prevalence and spectrum…
A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, Canada,…
Taking hormonal contraceptives, such as “the pill”, adds to breast cancer risk for women with…
BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of…
DNA can be damaged by toxins, radiation, or even normal cell division, but human cells…
New research, published in Nature Genetics, shows that more people may benefit from PARP inhibitor drugs,…
Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly…
The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been recommended…
The Institute of Cancer Research, London, UK, strongly welcomes new findings that the targeted drug…